FDA Eyes Manufacturing Innovation to Boost Drug Development

New technologies, along with changes in FDA oversight, may provide a critical path to make more new drugs available more quickly to patients.

Related Content:

ManufacturingQuality SystemsRegulatory Oversight and CompliancePharmaceutical Technology-05-02-2004

A CDMO’s Role in API Quality

FDA Grants Fast Track Designation to Teva Celiac Disease Candidate

GSK, Spero Therapeutics Oral UTI Treatment Trial Stopped Early for Efficacy